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ABSTRACT  
          Marine-derived fungi have been proven to be rich sources 
of chemically diverse natural products with a broad range of 
biological activities. The aim of this study was to determine the 
antibacterial and antiangiogenesis activities of marine derived 
fungi Dactylaria sp. Cultivation of the fungus Dactylaria sp (strain 
TID 24041021-1) was isolated from the marine invertebrate 
sponge. Culture of marine fungus was macerated with acetone 
and partitioned with ethyl acetate. The ethyl acetate extracts with 
50, 100, and 200μg/mL concentrations, were assayed for their 
antiangiogenic activity by using chorioallantoic membrane in vivo. 
At the same time, ethyl acetate extracts at levels of 5, 10, 15, 
and 20mg/mL were assayed to pathogenic bacteria Bacillus 
subtilis, Escherichia coli, and Staphylococcus aureus using well 
diffusion method. The result of this study showed that ethyl 
acetate extract at concentration 50μg/mL could inhibit  
angiogenesis. The best antiangiogenic activity was showed at 
concentration of 200μg/mL ethyl acetate extract. Antibacterial 
activity from ethyl acetate extract inhibited the growth of B. 
subtilis (2.25-5mm), E. coli (0.63-3.50mm) and S. aureus (0-
1.75mm) bacteria. 
 




Angiogenesis is a multistep process, 
leading to the formation of new blood vessels 
from the existing ones. It occurs during 
embryonic development, endometrial regulation, 
reproductive cycle, and wound healing. 
Angiogenesis also plays a critical role in many 
disease conditions like solid tumor progression, 
metastasis, diabetic retinopathy, arthritis, 
psoriasis, hemangiomas, and atherosclerosis 
(Folkman, 1995). New blood vessels are needed 
to supply oxygen and nutrition into tumor cells, 
so that tumor cells can keep growing, 
developing or even metastases (Hanahan, 
1996). Based on this evidence, angiogenesis can 
be said act as main concept of tumors growth. 
Antiangiogenesis is inhibition of blood vessel 
growth, as a way of treating primary tumors 
and reducing their metastases (Folkman, 1971). 
Angiogenesis inhibitors are described as class 1 
(specific and semi-specific) and class 2 (non-
specific), depending on whether they inhibit 
proliferation and/or migration of endothelial 
cells only, or are also toxic for tumor cells 
(Voest, 1996). 
Bacterial infection causes high rate of 
mortality in human population and aquaculture 
organisms. For an example, B.subtilis is 
responsible for causing food borne 
gastroenteritis. E.coli, S. aureus and Ps.aeruginosa 
cause diseases like mastitis, abortion and upper 
respiratory complications, while Salmonella sp. 
causes diarrhea and typhoid fever (Leven, 1987; 
Jawetz et al., 1985). Usage of antibiotics 
increased significantly due to heavy infections 
and the pathogenic bacteria becoming resistant 
to drugs is common due to indis-criminate use 
of antibiotics it becomes a greater problem of 
giving treatment against resistant pathogenic 
bacteria (Sieradzki et al., 1999). Decreased 
efficiency and resistance of pathogen to 
antibiotics has necessitated the development of 
new alternatives (Smith et al., 1994). Sponge-
derived fungi are a rich source of new natural 
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products with a wide range of biological 
activities for example enzyme inhibitor, 
anticancer, antitumor, antiangiogenesis and 
antibacterial. The aim of this study is to 
evaluate antiangiogenesis and antibacterial 





Marine invertebrate sponge was collected 
by snorkeling at -1~-5m depth from Tidung 
Island Kepulauan Seribu on April 2010. A 
specimen was deposited at the Laboratory of 
Microbiology, Faculty of Science and 
Mathematics Pelita Harapan University, 
Tangerang-Indonesia, under 5-10°C. Then, the 
specimen of marine-derived fungus was 
identified and isolated. 
 
Isolation and culture conditions 
Sponges were rinsed with sterile sea 
water, cut in small pieces, and put in PDB 
medium. 1mL of PDB was transferred to the 
35ppm salinity PDA medium and incubated in 
25°C for 7 days. Fungal isolates were obtained 
in pure cultures by single conidial transfer to 
150 PDA plates at 25°C for 21 days. 
 
Identification of fungi 
The isolated fungi were identified to the 
genus level and to the species when possible on 
the basis of macro morphological and micro 
morphological characteristics using PDA 
medium, slide cultures and the most updated 
keys for identifications. 
 
Macroscopic study 
Colonies of marine fungi were cultivated 
on PDA medium at 25°C for 5 days. The 
following morphological characteristics were 
evaluated: colony growth (length and width), 
presence or absence of aerial mycelium, colony 
color, presence of wrinkles and furrows, 
pigment production etc. 
 
Microscopic study 
Fungal spores were cultivated on PDA 
in Glass microscopes slides at 25°C for 6 days. 
The germination and growth of mycelium was 
observed daily under a light microscope. 
 
Extraction 
The cultured plates (150 plates) were 
extracted with acetone three times and filtered. 
The extract was obtained after removing the 
solvent under reduced pressure on a rotary 
evaporator. The resulting residue was 
partitioned between ethyl acetate and water to 
give 300mg of ethyl acetate extract. 
 
Antiangiogenesis assay 
Antiangiogenesis activity was using chick 
chorioallantoic membrane (CAM) method. 
Fertilized chicken eggs were cleaned with a 
70% alcohol solution and incubated at 37-38°C 
with approximately 60-75% humidity. After 
eight days chick embryos was exposed by 
making a window 20mm in the egg shell. The 
sterile paper discs were impregnated with 
extract solution (50, 100, dan 200μg/mL.) to 
achieve desired concentration and placed in 
CAM.  
Blank paper disc of 6mm diameter were 
used as normal control, paper disc of colostrum 
(10µL) as positive controls and paper disc of 
colostrum (50µg/mL) + ethyl acetate (10µL) 
using for solvent control. The window was 
sealed and the eggs were reincubated. On day 
13, the window is opened for observation. 
Angiogenic reaction around paper disc were 
calculated and scored 0, +1, +2 and +3. Score 
0 is no reaction observed, CAM normal. Score 
+1 is weak antiangiogenic response, score +2 is 
middle antiangiogenic response, and score +3 is 




In vitro anti-bacteria studies were carried 
out by the agar well diffusion method. The 
used indicator of inhibition activity was Gram-
negative bacteria (E. coli ATCC 25922) and 
Gram-positive bacteria (B. subtilis ATCC 6633 
and S. aureus ATCC 25923). All of the test 
microorganisms were obtained from the 
Laboratorium Pengembangan Teknologi 
Industri Agro dan Biomedika BPPT-Indonesia. 
The Pathogen bacteria was transferred to 
10ml Nutrient Broth (NB) and incubated for 
24h at 35°C. The prepared culture was 
appropriately diluted to achieve an inoculums 
size of approximately 106cfu/mL. Then, 0.5mL  
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inoculums were added to 20mL melted 
Nutrient Agar (NA) cooled at 45°C. These 
were then poured into 90mm diameter Petri 
dishes and maintained for 3h at room 
temperature. A 6mm diameter wells were cut in 
the agar plate. The ethyl acetate extract were 
applied to the wells with the concentration 5, 
10, 15, and 20mg/mL. Pure extraction solvent 
(Ethyl acetate) 50µL were used as solvent 
control and Amoxicillin 50g/mL were used as 
positive control. The plates were incubated at 
37°C for 24 hours and antimicrobial activities 
were determined by measuring the diameter of 
the inhibitory zones in millimeter. 
 
Statistical analysis 
The mean values were statistically 
analyzed using program SPSS (Statistical 
Package for the Social Sciences) 19.0 for windows 
program by the general one-way analysis of 
variance (ANOVA) to find out the most 
effective marine fungi extract and the most 
sensitive test microorganisms. 
 
RESULTS AND DISCUSSION 
Identification of marine fungi 
Fungi (TID.24041021-1) were identified 
in microscopic using light microscope. Hyphae 
are septate with conidiophores that are hyaline, 
erect, and sometimes knobby or bent at the 
point of conidial formation. Conidia (average 
3.5 x 10μm) from on threadlike denticles, they 
are brownish, two celled, oval to tear shaped, 
and typically have a marked constriction at the 
central ceptum. A frill of the denticle often 
remains on the base of the conidium after 
detachment from the conidiophores. Young 
conidia may be round and single celled (Figure 
1). Surface of colony marine fungi is woolly and 
dark olive-gray, reddish brown or gray-black. 
Reverse is dark; a red to brown pigment usually 
diffuses into the medium (Figure 2). From 
microscopic and macroscopic study, marine 
fungi (TID.24041021-1) similar with the fungi 
Dactylaria sp. (Larone, 2002). 
 
Antiangiogenesis activity 
On blank control (paper disc), there 
were a few new blood vessels growing to paper 
disc. It was caused by no colostrum         
containing angiogenesis given to normal control.         
Giving Calostrum® to CAM can stimulate new 
blood vessels forming. Calostrum® contains 
growth factor which can stimulate angiogenesis.  
Activity test result of antiangiogenesis 
ethyl acetate extract showed that the higher 
ethyl acetate extract concentration, the higher 
angionesis inhibition occurring on colostrum 
CAM induction as indicating by new blood 
vessels amount  reduction  (Figure  3   and     Table I).  
Ethyl acetate extract with concentration 
50μg/mL showed +2 on the inhibition of new 
blood vessels forming. It can be observed from 
the decreasing of the amount of blood vessels 
to paper disc compared with colostrum control 
+3 score. Ethyl acetate extract on 100μg/mL 
concentrations showed the same antiangiogenic 
activities as 50μg/mL concentrations, the given 
score is +2. Ethyl acetate extract of 200μg/mL 
showed the best antiangiogenesis activities with 
+3 score. It can be seen from the amount of 
blood vessels to paper disc is less than the 
amount of blood vessels of other treatments 
(Figure 3).  
On solvent control (colostrums + ethyl 
acetate 10μL), the amount of blood vessels on 
CAM is less than of on angionenic control 
(colostrum 60μg/mL), but on angiogenesis 
activity, the amount of blood vessel is equal to 
positive control.  
The main Growth factor in angiogenesis 
is basic fibroblast growth factor (bFGF) and 
vascular endothelial growth factor (VEGF). On 
tumor cell, secreted bFGF and VEGF will 
form new blood vessels to meet tumor’s cells 
nutrition. It enables to occur metastasis on 
tumor cells. Crude extract ethyl acetate is 
antiangiogenic, unfortunately its inhibition 
mechanisms have not been known yet.  
The inhibition mechanisms of blood 
vessels forming by antiangiogenic compounds 
can be done in two categories. Firstly, agents 
that blocked the activity of pro-angiogenic 
molecules, secondly, agents that directly 
affected endothelial cell function or survival 
(Ribati, 2010). Over 300 antiangiogenic 
molecules targeting different signaling pathways 
are being tested for their anticancer properties 
at preclinical and clinical stages. Although the 
results of the clinical trials are encouraging, the 
effects are modest. Clinical practice reveals that  
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therapy with angiogenesis inhibitors does not 
prolong survival of cancer patients for more 




Ethyl acetate extract was tested its 
ability to inhibit pathogen B. subtilis, E. coli, 
dan S. aureus bacteria using well diffusion 
method. The used concentrations were 5, 
10, 15, and 20mg/mL. The result of ethyl 
acetate extract inhibition toward pathogen 
bacteria  can  be observed on figure 4 based  
on figure 4 ethyl acetate extract has the first 
highest inhibition activity on B. Subtilis 
bacteria with inhibition diameter around 
5mm on 20mg/mL concentration. The 
second highest inhibition activity was 
found on E. coli bacteria with inhibition 
diameter 3,50mm on 20mg/mL concentra-
tion. The lowest inhibition activity was on 
S. aureus bacteria with inhibition diameter 
around 1,75mm on 20mg/mL concentra-
tion. The tested solvent control did not 
show  any  inhibition  activities  on bacteria.  
 
 
Figure 1. (1) Conidium; (2) Cell of fungi; (3) Septum; (4) Dentrikel; (5) Conidiophore; (6) Hifa. 
(A) Morphology of fungi Dactylaria constricta (Larone, 2002); (B) Illustration of fungi Dactylaria 





Figure  2. (a) Surface of colony marine fungi (TID.24041021-1) (b) Reverse of colony marine 
fungi (TID.24041021-1) 
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Angiogenic control 50µg/mL showed a 
high inhibition activity on B. Subtilis 14mm, 
E. coli 11,24mm, and S. aureus 13,00mm. 
Based on figure 4 can be seen there was any 
correlation between the increment   extract   
concentrations which caused the inhibition 
bacteria increment growing. Crude extract 
of ethyl acetate fungi (TID.24041021-1)  
can inhibit  three indicator pathogen bacteria;   
B. subtilis, S. aureus (Gram-positive bacteria), 
E. coli (Gram-negative bacteria). Generally, 
ethyl acetate extract has the possibility to 
have broad spectrum compounds in which 
effectively inhibit Gram-positive bacteria. 
Gram-negative bacteria were less sensitive 
than Gram-positive bacteria, which may           
be due to their differences in the cell         




Figure 3. The results of antiangiogenesis test observation on CAM from ethyl acetate extract fungi 
TID.21-1 
(a). Colostrum + ethyl acetate extract 50μg/mL (b). Colostrum + ethyl acetate extract 100μg/mL; (c). 
Colostrum + ethyl acetate extract 200μg/mL. (d). Positive control (colostrum 50μg/mL); (e). Solvent control 
(colostrum 50μg /mL + ethyl acetate 10μL), (f). Normal control (paper disc). 
 






Colostrum + ethyl acetate extract 50μg /mL 24.33 +2 
Colostrum + ethyl acetate extract 100μg /mL 21.33 +2 
Colostrum + ethyl acetate extract 200μg /mL 18.33 +3 
Positive control (Colostrum  50μg /mL) 40 +1 
solvent control (Colostrum 50μg /mL + Ethyl acetate 10μL) 37 +1 
Normal control (Paper disc)  7   0 
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It was interesting to note that tested 
bacteria showed more sensitivity to the 
investigated fungi extracts. This clearly 
indicates that active compounds of these 
extracts interfere with composition of 
Gram-negative bacteria cell wall. Ebell 
(2010), reported that the Isocyclocitrinol A 
from marine sponge derived fungi 
Penicillium citrinum showed antibacterial 
activity. Capon et al (2007), reported that 
diketopiperazines  isolated from a marine 
fungus Penicillium sp showed antibacterial 
(Escherichia coli and Bacillus subtilis), 
antifungal (Septoria nodurun) and antiparasitic 
(Haemonchus contortus) activities.  
 
CONCLUSIONS   
 Ethyl acetate extract of marine fungi 
(strain TID.24041021-1) used in the present 
investigation showed better antiangiogenesis 
and antibacterial activities. They are potential 
sources of bioactive compounds and should be 
investigated for natural antiangiogenesis and 
antibiotics. But further study should be made to 
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